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Abstract 
Objective: Group B Streptococcus (GBS) is a leading cause of neonatal meningitis and sepsis worldwide. Intrapartum 
antibiotics given to women carrying GBS are an effective means of reducing disease in the first week of life. Rapid and 
reliable tests are needed to accurately identify GBS from these women for timely intrapartum antibiotic administra‑
tion to prevent neonatal disease. Many laboratories now use matrix‑assisted laser desorption ionisation time‑of‑flight 
mass spectrometry (MALDI‑TOF MS) by direct plating or cell lysis for the identification of GBS isolates. The cell lysis 
step increases time to results for clinical samples and is more complex to perform. Therefore, we seek to evaluate the 
sensitivity and specificity of the quicker and more rapid direct plating method in identifying GBS.
Results: We directly compared swab isolates analysed by both direct plating and cell lysis method and demonstrated 
that direct plating has a sensitivity and specificity of 0.97 and 1, respectively, compared to an additional cell lysis step. 
We demonstrated that MALDI‑TOF MS can be successfully used for batch processing by the direct plating method 
which saves time. These results are reassuring for laboratories worldwide who seek to identify GBS from swabs sam‑
ples as quickly as possible.
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Introduction
Group B Streptococcus (GBS or Streptococcus agalac-
tiae) is a Gram-positive bacterium found colonising in 
the genitourinary  and gastrointestinal tracts of approxi-
mately 20% of pregnant women [1–3]. Maternal coloni-
sation is the primary source of transmission in neonatal 
GBS infections as the bacterium can spread in utero, or 
from neonatal inhalation or ingestion of contaminated 
vaginal fluids. Infections can cause still- and preterm-
births, foetal sepsis, meningitis, pneumonia and neu-
rodevelopmental complications  in survivors of GBS 
meningitis [3, 4]. Intrapartum antibiotic prophylaxis 
(IAP) can be given to pregnant women in labour to pre-
vent neonatal early-onset disease if GBS has been iden-
tified by swab-based screening. However, culture-based 
methods of GBS detection can require a long turnaround 
time of 3–5  days [5] from swab being taken to results 
being given, and a number of women will not know their 
diagnosis before going into labour and will therefore not 
receive timely IAP.
Public Health England guidelines recommend inocu-
lating swabs in a selective enrichment broth prior to 
sub-culturing specimen on blood or chromogenic agar 
plates to detect GBS carriage [6]. Presumptive GBS colo-
nies from agar plates should then be confirmed through 
antigen-specific tests, biochemical tests and/or matrix-
assisted laser desorption ionisation time-of-flight mass 
spectrometry (MALDI-TOF MS) [7]. Antigenic or 
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biochemical tests are less favourable than MALDI-TOF 
MS as they offer lower sensitivity [5] and have been 
shown to cross-react to give false identification [8]. 
MALDI-TOF MS is quick, sensitive and economical. 
Currently, there are two sample preparation methods for 
MALDI-TOF MS analysis: direct plating or a full protein 
extraction by cell lysis [9, 10]. The direct plating method 
is considered to be less complex and more rapid than the 
cell lysis method. MALDI-TOF MS is 100% accurate for 
β-haemolytic Streptococcus [11], however Bizzini et  al., 
showed that MALDI-TOF MS identification accuracy 
can be influenced by preparatory methods used [12]. 
The use of and reliance on the accuracy of identification 
by MALDI-TOF MS is increasing in clinical laborato-
ries globally [13], with Food and Drug Administration 
approval for MALDI-TOF MS systems and time savings 
well documented [14]. It is important to ascertain the 
optimal methodology for GBS species identification for 
laboratories considering the increased use of MALDI-
TOF MS. In this study we describe the largest inves-
tigation of GBS isolates to date to inform microbiology 
laboratories guidance in the identification of GBS com-
paring direct plating and cell lysis MALDI-TOF MS pre-
paratory methods.
Main text
Methods
Bacterial isolates
947 Streptococcus, Lactococcus, Aerococcus and Weis-
sella spp. isolates were cultured from clinically diverse 
rectal, vaginal and nasopharyngeal swabs in skim milk, 
tryptone, glucose, and glycerin (STGG) from pregnant 
women and infants [15]. To culture the bacteria, 200  µl 
of STGG was inoculated in 2  ml LIM RambaQUICK 
StrepB (CHROMagar, France) and incubated at 37 °C in 
5%  CO2 for 6–24 h. 10 µl of overnight growth was plated 
on CHROMagar StrepB (CHROMagar, France) at 37  °C 
in 5%  CO2 for 18–24 h. Presumptive GBS colonies with a 
mauve morphology were selected to undergo a confirma-
tory test by MALDI-TOF MS. Bacteria plated on Colum-
bia blood agar (Oxoid, England) were incubated at 37 °C 
in 5%  CO2 for 18–24 h.
MALDI‑TOF MS preparation
Confirmation of bacterial species identification using 
MALDI-TOF MS were performed as previously 
described [11]. Briefly, for the direct colony method, 
a single colony was picked and spotted onto a steel tar-
get plate (Bruker Daltonics, Germany) and allowed 
to dry before overlaying with 1  µl of MALDI matrix 
(Bruker Daltonics, Germany), a solution of α-cyano-4-
hydroxycinnamic acid (HCCA) dissolved in 50% ace-
tonitrile and 2.5% trifluoroacetic acid. For the cell lysis 
method, 1 µl loopful of bacteria was taken and suspended 
in 300 µl of molecular grade water and vortexed. 900 µl 
of 100% ethanol was added, vortexed then centrifuged 
at 16,000g for 2 min. The supernatant was discarded and 
the pellet left to dry at room temperature. Next, the pellet 
was resuspended in 30 µl of 70% formic acid and 30 µl of 
100% acetonitrile then centrifuged at 16,000g for 2 min. 
1 µl of supernatant was spotted onto the target plate and 
1 µl of MALDI matrix directly overlaid. MALDI-TOF MS 
was performed using MALDI Biotyper (Bruker Dalton-
ics, Germany) according to manufacturer’s recommen-
dations. Spectra were analysed using Bruker Biotyper 
software (version 4.1.70). Using the manufacture’s cri-
teria, log scores ≥ 2.00 indicate identification to species 
level, scores 1.70–1.99 indicate genus identification, and 
scores < 1.70 were interpreted as unreliable and were 
repeated. Isolates were tested in duplicate and deemed 
reliable and correct if identification of the repeated sam-
ple was the same species.
API testing
API biochemical test strip kit (bioMérieux, USA) was 
used to identify the bacteria species of the nine discord-
ant results. The test was performed following manufac-
turer’s instructions. Results from the tests were analysed 
through APIWEB software (bioMérieux, USA).
Statistical analysis
Comparisons of genus-  or species-level identification 
using direct plating versus protein extraction method 
were made using McNemar’s paired test on GraphPad 
Prism (version 7.03). P value < 0.05 were considered sta-
tistically significant.
Results
MALDI‑TOF MS sample preparation methods
We compared the  direct plating method against a cell 
lysis method for MALDI-TOF MS analysis on 96 colo-
nies that exhibit similar morphologies to GBS on CHRO-
Magar from a sub-set of 33 clinically diverse swabs 
collected from mother-infant pairs. All isolates were 
identified to the genus level (log score 1.70–1.99) using 
either of the two methods. Cell lysis was able to identify 
91/96 isolates to the species-level (log score ≥ 2.00) and 
direct plating identified 88/96 (Table  1). Isolates were 
correctly identified by both methods as Streptococcus 
agalactiae (n = 36), Streptococcus salivarius (n = 1), Weis-
sella confusa (n = 2), Lactococcus garvieae (n = 45), Lac-
tococcus lactis (n = 8) and Aerococcus viridans (n = 4). 
The sensitivity and specificity for direct plating com-
pared to cell lysis were 0.97 and 1, respectively. Positive 
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and negative predictive values for this method were 1 and 
0.99, respectively.
Identification of GBS using CHROMagar and direct plating 
MALDI‑TOF MS method
We analysed 851 rectovaginal, rectal and nasopharyngeal 
swabs from 155 mother-infant pairs using the direct plat-
ing method for MALDI-TOF MS analysis. These swabs 
had initially been identified as GBS positive by Colum-
bia blood agar and confirmed using MALDI-TOF MS 
by direct plating. 842 (98.9%) isolates had the typical 
morphology of GBS and 9 (1.4%) isolates had morpholo-
gies not suggestive of the typical GBS appearance. The 
nine discordant samples had similar colony morpholo-
gies, with different colouration in some cases, to GBS 
on CHROMagar (Fig.  1) and were identified as GBS by 
the direct plating method on MALDI-TOF MS. These 
discrepant strains were subsequently re-analysed by API 
biochemical test strip kits and MALDI-TOF MS by cell 
lysis method as previously described [10], and were con-
firmed as Weissella confusa (n = 4), Streptococcus salivar-
ius (n = 2), Aerococcus viridans (n = 2) and Enterococcus 
faecalis (n = 1).
Discussion
To our knowledge, this is the largest study evaluating 
MALDI-TOF MS preparation methods for GBS iden-
tification from clinical specimens in combination with 
CHROMagar. Previous studies have demonstrated 
MALDI-TOF MS to be a valuable tool for identification 
of GBS with a high level of accuracy [10, 16, 17].
Several species such as Enterococcus spp., Streptococcus 
bovis, Streptococcus porcinus, Streptococcus pseudoporci-
nus, Streptococcus salivarius, Streptococcus thoralten-
sis, Streptococcus anginosus, Streptococcus pyogenes and 
Staphylococcus spp. have been documented to develop 
colonies that resemble GBS on chromogenic agar 
compared to blood agar [5]. In our study, we found that 
MALDI-TOF MS incorrectly identified 9 isolates that 
had morphology similar to GBS on CHROMagar. How-
ever, when we compared direct plating with cell lysis, we 
found no difference in either approach to accurately iden-
tify GBS.
MALDI-TOF MS is a powerful tool for microbial 
identification, however, for some microorganisms this 
instrument is unable to discriminate between genus and 
species due to lack of reference spectra [18, 19], low iden-
tification scores [20] or low resolution of phylogeneti-
cally similar species [1]. Poor sample preparation can also 
influence the quality of results and care must be made to 
ensure sample and matrix are air-dried to prevent liq-
uid smears and cross-contamination between spots on 
the target plate [12]. As MALDI-TOF MS spectra rely 
on the ionisation of proteins on the bacterial surface, 
some authors suggest that an additional cell lysis step is 
required for the species-level identification of Gram-
positive bacteria to lyse the peptidoglycan cell wall and 
enable unmasking of these surface proteins to increase 
the protein profile [12]. This is supported by this study 
in which increased species level detection was achieved 
using cell-lysis as opposed to direct plating. Some Strep-
tococcus species such as S. viridans [21], S. pneumoniae 
[22], and S. mitis [23] have been mis-identified through 
direct plating MALDI-TOF MS methods due to similari-
ties in protein mass spectra. However, in our study GBS 
was correctly identified by both methods.
Evaluation of both preparatory methods have been 
studied in smaller studies for GBS [10, 16, 24, 25] dem-
onstrating that direct plating gives high resolution in 
assigning species identification. In our study, we confirm 
that direct plating gives an accurate identification of GBS 
and species that resembled GBS on CHROMagar, with-
out the requirement of a cell lysis extraction.
Table 1 MALDI-TOF MS identification of  Streptococci, Lactococci, Weisella and  Aerococci to  genus- and  species-level 
by direct plating and cell lysis preparatory method
Organism Number 
of isolates
Direct plating Cell lysis
Genus-level 
identification only
Species-level 
identification
Genus-level 
identification only
Species-level 
identification
Streptococcus agalactiae 36 1 35 0 36
Streptococcus salivarius 1 1 0 0 1
Weissella confusa 2 0 2 0 2
Lactococcus garvieae 45 6 39 5 40
Lactococcus lactis 8 0 8 0 8
Aerococcus viridans 4 0 4 0 4
Total 96 8 88 5 91
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To conclude, the use of MALDI-TOF MS using direct 
plating preparatory methods is a reliable way to accu-
rately identify GBS in a clinical diagnostic laboratory. 
A marginal increase in species level detection can be 
achieved using cell lysis but requires considerable extra 
effort over and above direct plating and has no overall 
Fig. 1 Microbiological colony appearance on CHROMagar after 18–24 h incubation. a Lactococcus garvieae; b Aerococcus viridans; c Weissella 
confusa; d Lactococcus lactis; e Streptococcus salivarius; f Entercoccus faecalis and g Group B Streptococcus 
Page 5 of 6To et al. BMC Res Notes           (2019) 12:85 
effect on the specificity of GBS identification. Accurate 
bacterial species identification is key to the timely admin-
istration of IAP and can directly influence clinical care 
in cases with GBS that can be facilitated by MALDI-
TOF  MS [5]. The direct plating method is less time-
consuming for large sample numbers as the application 
takes minutes whilst the cell lysis procedure can take half 
a day when batch processing. This makes direct plating 
more favourable in hospital diagnostic settings where 
rapid results are critical to determine whether a patient 
requires time-critical treatment, such as correctly identi-
fying a woman requiring intrapartum antibiotic prophy-
laxis to prevent transmission of GBS, or to determine the 
best course of treatment in the case of infant GBS menin-
gitis or sepsis.
Limitations
Although we cannot explain the reason for the nine dis-
cordant results found, API biochemical tests confirmed 
the isolates to be non-GBS. Since we have shown that 
both MALDI-TOF MS preparatory methods consistently 
gave reliable identification of GBS, the reason for the dis-
cordance requires further investigation. It could reflect 
either lack of purity of colonies on agar plate, storage of 
the inappropriate strain or a potential contamination 
during sample preparation on the target MALDI-TOF 
MS plate.
Authors’ contributions
KT, EC and RD performed the experiments. KT carried out the data analysis 
and drafted the manuscript. KLD, EJ and VC conceived the original idea. 
KLD, EJ, VC and SG contributed to manuscript revisions. All authors read and 
approved the final manuscript.
Author details
1 Section of Paediatrics, Department of Medicine, Imperial College London, 
London, UK. 2 Centre for Infection and Immunity, St George’s University 
of London, London, UK. 3 Public Health England, London, UK. 4 Infection 
and Immunity, Department of Microbiology, Charing Cross Hospital, London, 
UK. 5 Department of Infectious Disease Epidemiology, Imperial College Lon‑
don, London, UK. 
Acknowledgements
We thank the microbiology laboratory at Charing Cross Hospital, Imperial 
College Healthcare NHS Trust London, and Public Health England Respira‑
tory and Vaccine Preventable Bacteria Reference Unit team for the use of the 
MALDI‑TOF MS instruments.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
Datasets used during this study are available from the corresponding author 
on reasonable request.
Consent to publish
Not applicable.
Ethics approval and consent to participate
Not applicable.
Funding
KT and KLD are funded by The Bill & Melinda Gates Foundation and Thrasher 
Research Fund; EJ is jointly funded by Rosetrees Trust and The Stoneygate 
Trust. The funders had no role in study design, data collection and analysis, 
decision to publish, or preparation of the manuscript.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
Received: 18 December 2018   Accepted: 6 February 2019
References
 1. Khot PD, Fisher MA. Novel approach for differentiating Shigella species 
and Escherichia coli by matrix‑assisted laser desorption ionization–time of 
flight mass spectrometry. J Clin Microbiol. 2013;51:3711–6.
 2. Russell NJ, Seale AC, O’Driscoll M, et al. Maternal colonization with group 
b streptococcus and serotype distribution worldwide: systematic review 
and meta‑analyses. Clin Infect Dis. 2017;65:S100–S111111.
 3. Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases, National‑
Center for Immunization and Respiratory Diseases C for DC and P (CDC). 
Prevention of perinatal group B streptococcal disease—revised guide‑
lines from CDC, 2010. MMWR Recomm reports Morb Mortal Wkly report 
Recomm reports. 2010;59:1–36.
 4. Kohli‑Lynch M, Russell NJ, Seale AC, et al. Neurodevelopmental impair‑
ment in children after Group B Streptococcal disease worldwide: system‑
atic review and meta‑analyses. Clin Infect Dis. 2017;65:S190–S199199.
 5. Rosa‑Fraile M, Spellerberg B. Reliable detection of Group B Streptococcus 
in the clinical laboratory. J Clin Microbiol. 2017;55:2590–8.
 6. Public Health England (2018) SMI B 58: detection of carriage of group B 
streptococci ‑ GOV.UK.
 7. Public Health England. UK standards for microbiology Investigations 
identification of Streptococcus species Enterococcus species and mor‑
phologically similar organisms. London: Public Health England; 2014.
 8. Suwantarat N, Grundy M, Rubin M, et al. Recognition of Streptococcus 
pseudoporcinus colonization in women as a consequence of using 
matrix‑assisted laser desorption ionization‑time of flight mass spec‑
trometry for Group B Streptococcus Identification. J Clin Microbiol. 
2015;53:3926–30.
 9. Drevinek M, Dresler J, Klimentova J, Pisa L, Hubalek M. Evaluation of 
sample preparation methods for MALDI‑TOF MS identification of highly 
dangerous bacteria. Lett Appl Microbiol. 2012;55:40–6.
 10. Alatoom AA, Cunningham SA, Ihde SM, Mandrekar J, Patel R. Comparison 
of direct colony method versus extraction method for identification 
of Gram‑positive Cocci by use of Bruker biotyper matrix‑assisted laser 
desorption ionization‑time of flight mass spectrometry. J Clin Microbiol. 
2011;49:2868–73.
 11. Lartigue M‑F, Hery‑Arnaud G, Haguenoer E, Domelier A‑S, Schmit P‑O, 
van der Mee‑Marquet N, Lanotte P, Mereghetti L, Kostrzewa M, Quentin 
R. Identification of Streptococcus agalactiae isolates from various phyloge‑
netic lineages by matrix‑assisted laser desorption ionization‑time of flight 
mass spectrometry. J Clin Microbiol. 2009;47:2284–7.
 12. Bizzini A, Durussel C, Bille J, Greub G, Prod’hom. Performance of matrix‑
assisted laser desorption ionization‑time of flight mass spectrometry for 
identification of bacterial strains routinely isolated in a clinical microbiol‑
ogy laboratory. J Clin Microbiol. 2010;48:1549–54.
 13. Raoult D, Diawara S, Mediannikov O, et al. The ongoing revolution of 
MALDI‑TOF mass spectrometry for microbiology reaches tropical Africa. 
Am J Trop Med Hyg. 2015;92:641–7.
 14. Theparee T, Das S, Thomson RB. total laboratory automation and matrix‑
assisted laser desorption ionization‑time of flight mass spectrometry 
improve turnaround times in the clinical microbiology laboratory: a 
retrospective analysis. J Clin Microbiol. 2018;56:e01242–e1317.
 15. Le Doare K, Jarju S, Darboe S, Warburton F, Gorringe A, Heath PT, Kamp‑
mann B. Risk factors for Group B Streptococcus colonisation and disease 
in Gambian women and their infants. J Infect. 2016;72:283–94.
Page 6 of 6To et al. BMC Res Notes           (2019) 12:85 
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 16. Binghuai L, Yanli S, Shuchen Z, Fengxia Z, Dong L, Yanchao C. Use of 
MALDI‑TOF mass spectrometry for rapid identification of group B Strepto‑
coccus on chromID Strepto B agar. Int J Infect Dis. 2014;27:44–8.
 17. Lartigue M‑F, Kostrzewa M, Salloum M, Haguenoer E, Héry‑Arnaud G, 
Domelier A‑S, Stumpf S, Quentin R. Rapid detection of “highly virulent” 
Group B Streptococcus ST‑17 and emerging ST‑1 clones by MALDI‑TOF 
mass spectrometry. J Microbiol Methods. 2011;86:262–5.
 18. Emami K, Nelson A, Hack E, Zhang J, Green DH, Caldwell GS, Mesbahi 
E. MALDI‑TOF mass spectrometry discriminates known species and 
marine environmental isolates of Pseudoalteromonas. Front Microbiol. 
2016;7:104.
 19. Lee M‑R, Tsai C‑J, Teng S‑H, Hsueh P‑R. Identification of Weissella species 
by matrix‑assisted laser desorption/ionization time‑of‑flight mass spec‑
trometry. Front Microbiol. 2015;6:1246.
 20. Khot PD, Couturier MR, Wilson A, Croft A, Fisher MA. Optimization of 
matrix‑assisted laser desorption ionization‑time of flight mass spectrom‑
etry analysis for bacterial identification. J Clin Microbiol. 2012;50:3845–52.
 21. van Veen SQ, Claas ECJ, Kuijper EJ. High‑throughput identification of 
bacteria and yeast by matrix‑assisted laser desorption ionization‑time of 
flight mass spectrometry in conventional medical microbiology laborato‑
ries. J Clin Microbiol. 2010;48:900–7.
 22. Seng P, Drancourt M, Gouriet F, La Scola B, Fournier P, Rolain JM, Raoult D. 
Ongoing revolution in bacteriology: routine identification of bacteria by 
matrix‑assisted laser desorption ionization time‑of‑flight mass spectrom‑
etry. Clin Infect Dis. 2009;49:543–51.
 23. De Bel A, Wybo I, Pierard D, Lauwers S, van Veen SQ, Claas ECJ, Kuijper EJ. 
Correct implementation of matrix‑assisted laser desorption ionization‑
time of flight mass spectrometry in routine clinical microbiology. J Clin 
Microbiol. 2010;48:1991–2.
 24. Ábrók M, Arcson Á, Lázár A, Urbán E, Deák J. Combination of selective 
enrichment and MALDI‑TOF MS for rapid detection of Streptococcus 
agalactiae colonisation of pregnant women. J Microbiol Methods. 
2015;114:23–5.
 25. Moon H‑W, Lee SH, Chung H‑S, Lee M, Lee K. Performance of the Vitek MS 
matrix‑assisted laser desorption ionization time‑of‑flight mass spectrom‑
etry system for identification of Gram‑positive cocci routinely isolated in 
clinical microbiology laboratories. J Med Microbiol. 2013;62:1301–6.
